Illumina to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
Rhea-AI Summary
Illumina, Inc. (NASDAQ:ILMN) will release its third quarter 2021 financial results on November 4, 2021, after market close. A conference call with CEO Francis deSouza and CFO Sam Samad is scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss the results. Participants can access the call via Illumina's website or by dialing the provided numbers. A replay will be available for 30 days. Illumina continues to lead in DNA sequencing and genomics, serving various markets including life sciences and oncology.
Positive
- Illumina's upcoming conference call provides an opportunity for investor engagement.
- The company maintains its leadership in the rapidly growing genomics market.
Negative
- None.
News Market Reaction – ILMN
In the trading session that priced this news, ILMN gained 0.73%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 13, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2021 following the close of market on Thursday, November 4, 2021.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, November 4, 2021. Interested parties may access the live teleconference through the Investor Info section of Illumina's website under the "company" tab at www.illumina.com. Alternatively, individuals can access the call by dialing 1 (844) 200-6205 or 1 (929) 526-1599 outside North America, both with Conference ID 808648. To ensure timely connection, please dial in at least ten minutes before the scheduled start of the call.
A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Brian Blanchett
+1.858.291.6421
ir@illumina.com
Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-announce-third-quarter-2021-financial-results-on-thursday-november-4-2021-301399779.html
SOURCE Illumina, Inc.